Wheat oral immunotherapy was moderately successful but was associated with very frequent adverse events in children aged 6 ‐18 years

ConclusionThe majority (57%) of children with wheat allergies could use wheat in their daily diet 16 months after the initiation of oral immunotherapy, but 94/100 had adverse reactions and 60 were moderate or severe. Specific immunoglobulin E to omega‐5‐gliadin may provide a biomarker for how much wheat can be tolerated and the intensity of the reactions to immunotherapy.This article is protected by copyright. All rights reserved.

Source: Acta Paediatrica - January 18, 2018 Category: Pediatrics Authors: Petri Kulmala, Anna S Pelkonen, Mikael Kuitunen, Marita Paassilta, Sami Remes, R üdiger Schultz, Teija Dunder, Sami Turunen, Mika J. Mäkelä Tags: Regular Article Source Type: research